tradingkey.logo

Hims & Hers Health Inc

HIMS

62.550USD

-3.630-5.49%
Fechamento 08/01, 16:00ETCotações atrasadas em 15 min
13.99BValor de mercado
85.07P/L TTM

Hims & Hers Health Inc

62.550

-3.630-5.49%
Mais detalhes de Hims & Hers Health Inc Empresa
Hims & Hers Health, Inc. provides a consumer-first platform, which helps customers to fulfill their health and wellness needs. Its platform includes access to a provider network, a clinically focused electronic medical record system, digital prescriptions, cloud pharmacy fulfillment, and personalization capabilities. Its digital platform enables access to treatments for a range of chronic conditions, including those related to sexual health, hair loss, dermatology, mental health, and weight loss. It connects patients to licensed healthcare professionals who can prescribe medications when appropriate and prescriptions are fulfilled online through licensed pharmacies on a subscription basis. It also offers access to a range of health and wellness products designed to meet individual needs, which can include curated prescription and non-prescription products. Through its mobile applications, consumers can access a range of educational programs, wellness content, and other services.
Informações da empresa
Código da empresaHIMS
Nome da EmpresaHims & Hers Health Inc
Data de listagemSep 09, 2019
Fundado em2021
CEOMr. Andrew Dudum
Número de funcionários1637
Tipo de títulosOrdinary Share
Fim do ano fiscalSep 09
Endereço2269 Chestnut St
CidadeSAN FRANCISCO
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal94123
Telefone14158510195
Sitehttps://www.forhims.com/
Código da empresaHIMS
Data de listagemSep 09, 2019
Fundado em2021
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Andrew Dudum
Mr. Andrew Dudum
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
10.23M
-0.03%
Ms. Soleil Boughton
Ms. Soleil Boughton
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
155.59K
-3.20%
Mr. Oluyemi Okupe
Mr. Oluyemi Okupe
Chief Financial Officer
Chief Financial Officer
123.60K
-6.88%
Ms. Christiane Pendarvis
Ms. Christiane Pendarvis
Independent Director
Independent Director
36.56K
+37.31%
Mr. Kare Schultz
Mr. Kare Schultz
Independent Director
Independent Director
9.12K
--
Mo Elshenawy
Mo Elshenawy
Chief Technology Officer
Chief Technology Officer
--
--
Mr. Nader Kabbani
Mr. Nader Kabbani
Chief Operating Officer
Chief Operating Officer
--
--
Mr. David Wells
Mr. David Wells
Lead Independent Director
Lead Independent Director
--
--
Dr. Delos Cosgrove, M.D.
Dr. Delos Cosgrove, M.D.
Independent Director
Independent Director
--
--
Mr. Christopher D. Payne
Mr. Christopher D. Payne
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Andrew Dudum
Mr. Andrew Dudum
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
10.23M
-0.03%
Ms. Soleil Boughton
Ms. Soleil Boughton
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
155.59K
-3.20%
Mr. Oluyemi Okupe
Mr. Oluyemi Okupe
Chief Financial Officer
Chief Financial Officer
123.60K
-6.88%
Ms. Christiane Pendarvis
Ms. Christiane Pendarvis
Independent Director
Independent Director
36.56K
+37.31%
Mr. Kare Schultz
Mr. Kare Schultz
Independent Director
Independent Director
9.12K
--
Mo Elshenawy
Mo Elshenawy
Chief Technology Officer
Chief Technology Officer
--
--
Detalhamento da receita
Moeda: USDAtualizado em: dom, 6 de jul
Moeda: USDAtualizado em: dom, 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
Por EmpresaUSD
Nome
Receita
Proporção
Online
576.36M
98.35%
Wholesale
9.65M
1.65%
Por RegiãoUSD
Nome
Receita
Proporção
United States
586.01M
100.00%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Online
576.36M
98.35%
Wholesale
9.65M
1.65%
Distribuição de ações
Atualizado em: sáb, 19 de jul
Atualizado em: sáb, 19 de jul
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
10.12%
The Vanguard Group, Inc.
8.56%
Capital Research Global Investors
6.86%
Dudum (Andrew)
4.75%
Abraham (Jack)
4.33%
Other
65.39%
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
10.12%
The Vanguard Group, Inc.
8.56%
Capital Research Global Investors
6.86%
Dudum (Andrew)
4.75%
Abraham (Jack)
4.33%
Other
65.39%
Tipos de investidores
Investidores
Proporção
Investment Advisor
40.93%
Investment Advisor/Hedge Fund
15.55%
Hedge Fund
15.50%
Individual Investor
11.17%
Research Firm
7.56%
Pension Fund
1.22%
Bank and Trust
0.67%
Venture Capital
0.42%
Private Equity
0.35%
Other
6.63%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
873
201.24M
93.40%
-32.91M
2025Q1
847
185.19M
85.97%
-48.88M
2024Q4
739
195.19M
91.41%
-9.62M
2024Q3
627
167.49M
80.36%
-35.34M
2024Q2
588
165.89M
79.48%
-12.74M
2024Q1
503
156.70M
75.98%
-10.05M
2023Q4
463
153.90M
75.37%
-26.71M
2023Q3
444
160.41M
78.97%
-33.55M
2023Q2
426
173.15M
85.66%
-3.29M
2023Q1
404
156.26M
77.80%
-6.84M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
BlackRock Institutional Trust Company, N.A.
21.80M
10.12%
-5.83M
-21.10%
Mar 31, 2025
The Vanguard Group, Inc.
18.44M
8.56%
-1.78M
-8.80%
Mar 31, 2025
Dudum (Andrew)
10.23M
4.75%
+5.79K
+0.06%
Jun 17, 2025
Abraham (Jack)
9.32M
4.33%
-2.62M
-21.93%
Dec 31, 2023
Farallon Capital Management, L.L.C.
7.95M
3.69%
-423.30K
-5.05%
Mar 31, 2025
Goldman Sachs & Company, Inc.
7.72M
3.58%
+2.53M
+48.65%
Mar 31, 2025
State Street Global Advisors (US)
7.44M
3.45%
-329.75K
-4.24%
Mar 31, 2025
Renaissance Technologies LLC
7.02M
3.26%
+73.20K
+1.05%
Mar 31, 2025
D. E. Shaw & Co., L.P.
6.03M
2.8%
+5.39M
+841.74%
Mar 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: há uma hora
Atualizado em: há uma hora
Nome
Proporção
Amplify Weight Loss Drug & Treatment ETF
6.91%
Invesco Dorsey Wright Healthcare Momentum ETF
4.75%
Global X HealthTech ETF
4.61%
First Trust Nasdaq Lux Digi Health Solutions ETF
3.95%
Invesco S&P MidCap 400 Pure Growth ETF
2.82%
Fidelity Digital Health ETF
2.74%
Pinnacle Focused Opportunities ETF
2.72%
VanEck Social Sentiment ETF
2.41%
Amplify Online Retail ETF
2.17%
Invesco S&P MidCap 400 GARP ETF
1.96%
Ver Mais
Amplify Weight Loss Drug & Treatment ETF
Proporção6.91%
Invesco Dorsey Wright Healthcare Momentum ETF
Proporção4.75%
Global X HealthTech ETF
Proporção4.61%
First Trust Nasdaq Lux Digi Health Solutions ETF
Proporção3.95%
Invesco S&P MidCap 400 Pure Growth ETF
Proporção2.82%
Fidelity Digital Health ETF
Proporção2.74%
Pinnacle Focused Opportunities ETF
Proporção2.72%
VanEck Social Sentiment ETF
Proporção2.41%
Amplify Online Retail ETF
Proporção2.17%
Invesco S&P MidCap 400 GARP ETF
Proporção1.96%
Dividendo
Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
KeyAI